SLC6A6 and colorectal carcinoma: Since higher levels of SLC6A6 are associated with maintenance of stem-cells properties and with chemoresistance [33] restoring miR-30b could be a promising strategy for the treatment of CRC patients of the High-stroma/CMS4 subtype.